Diabetes Current Affairs

14 November: World Diabetes Day

The World Diabetes Day was observed every year across the world on 14 November to raise awareness about diabetes. Observance of day aims to pursue multilateral efforts to promote and improve human health and provide access to health-care treatment and education.

The theme for year 2017 is “Women and diabetes – Our right to a healthy future’. It aims to promote affordable access to essential diabetes medicines and technologies for all women with diabetes to achieve optimal diabetes outcomes and strengthen their capacity to prevent type 2 diabetes.

Women and Diabetes

Diabetes is ninth leading cause of death in women globally, causing 2.1 million deaths each year. Currently, there are over 199 million women living with diabetes and it is projected to increase to 313 million by 2040. Two out of every five women with diabetes are of reproductive age which accounts for over 60 million women worldwide. Women with diabetes have more difficulty conceiving and may have poor pregnancy outcomes.

Background

The World Diabetes Day was instituted by United Nations General Assembly (UNGA) in 2007 by passing resolution A/RES/61/225. The resolution had encouraged Member States to develop national policies for prevention, treatment and care of diabetes.

Diabetes

Diabetes is a chronic, progressive non-communicable disease (NCD) characterized by elevated levels of blood sugar (blood glucose). It occurs when (i) the pancreas does not produce enough of the insulin hormone, which regulates blood sugar (ii) the body cannot effectively use the insulin it produces. Type 1 diabetes occurs when the body doesn’t make enough insulin, and type 2 diabetes occurs when the body doesn’t make or use insulin very well, causing glucose to remain in the blood, which can lead to serious problems.

Tags:

CSIR launches India’s first anti diabetic ayurvedic drug BGR -34

The Council for Scientific and Industrial Research (CSIR) has launched BGR-34, an anti-diabetic ayurvedic drug designed for type 2 Diabetes mellitus.

The anti-diabetic ayurvedic drug BGR-34 has been jointly developedby National Botanical Research Institute (NBRI) and Central Institute for Medicinal and Aromatic Plants (CIMAP).

About BGR-34

  • BGR-34 works by controlling blood sugar and limiting the harmful effects and toxicity of other drugs.
  • It contains 34 identified active phyto-constitutes from herbal resources.
  • It has been economically priced at 5 rupees per tablet as compared to latest DPP4 inhibitors globally.

About Council of Scientific and Industrial Research (CSIR)

  • CSIR is an autonomous body and the largest research and development (R&D) organisation in India.
  • It was established in 1942. It operates as an autonomous body registered under the Registration of Societies Act of 1860.
  • It is mainly funded by the Union Ministry of Science and Technology.
  • CSIR’s R&D activities include aerospace engineering, ocean sciences, structural engineering, metallurgy, life sciences, chemicals, mining, food, petroleum, leather, and environment.

Tags:

Advertisement

123